Ironwood Pharmaceuticals, Inc. - Class A
IRWD Real Time Price USDRecent trades of IRWD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IRWD's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
IRWD Revenue by Segment or Geography
New patents grants
-
Patent Title: Stable formulations of linaclotide Jul. 07, 2020
-
Patent Title: Stable formulations of linaclotide Jun. 09, 2020
-
Patent Title: Sgc stimulators Jan. 29, 2019
-
Patent Title: Sgc stimulators Jan. 22, 2019
-
Patent Title: Sgc stimulators Aug. 14, 2018
-
Patent Title: Imidazotriazinone compounds May. 15, 2018
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 12, 2017
-
Patent Title: Imidazotriazinone compounds Aug. 08, 2017
-
Patent Title: Treatments for gastrointestinal disorders Jul. 18, 2017
-
Patent Title: Faah inhibitors May. 23, 2017
-
Patent Title: Treatments for gastrointestinal disorders May. 16, 2017
-
Patent Title: Treatments for gastrointestinal disorders Apr. 11, 2017
-
Patent Title: Sgc stimulators Mar. 07, 2017
-
Patent Title: Imidazotriazinone compounds Jan. 10, 2017
-
Patent Title: Treatments for gastrointestinal disorders Dec. 27, 2016
-
Patent Title: Sgc stimulators Nov. 08, 2016
-
Patent Title: Sgc stimulators Nov. 01, 2016
-
Patent Title: Sgc stimulators Apr. 12, 2016
-
Patent Title: Treatments for gastrointestinal disorders Apr. 05, 2016
-
Patent Title: Compositions comprising bile acid sequestrants for treating esophageal disorders Dec. 08, 2015
-
Patent Title: 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators Sep. 22, 2015
-
Patent Title: Sgc stimulators Jun. 23, 2015
-
Patent Title: Nonoate derivatives and uses thereof May. 05, 2015
-
Patent Title: Treatments of gastrointestinal disorders Feb. 03, 2015
-
Patent Title: Indole compounds Nov. 11, 2014
-
Patent Title: Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration Aug. 12, 2014
-
Patent Title: Methods and compositions for the treatment of heart failure and other disorders Jul. 15, 2014
-
Patent Title: Formulations comprising linaclotide Jun. 10, 2014
-
Patent Title: Sgc stimulators Jun. 10, 2014
-
Patent Title: Treatments for gastrointestinal disorders May. 27, 2014
-
Patent Title: Crth2 modulators Mar. 18, 2014
-
Patent Title: Treatments for gastrointestinal disorders Aug. 13, 2013
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Feb. 07, 2012
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jan. 24, 2012
-
Patent Title: Compounds and methods for the treatment of asthma Jan. 03, 2012
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 20, 2011
-
Patent Title: Useful indole compounds Jun. 14, 2011
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Mar. 22, 2011
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Aug. 10, 2010
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jun. 29, 2010
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Apr. 27, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to IRWD
Recent picks made for IRWD stock on CNBC
ETFs with the largest estimated holdings in IRWD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $IRWD stock a Buy, Sell, or Hold?
- What is the price target for $IRWD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $IRWD stock?
- Who owns the most shares of $IRWD stock?
- What funds own $IRWD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IRWD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.